BIOMEDICAL
BIOMEDICAL, also known as Bio-Medical, is a prominent player in the biomedical industry, headquartered in CL. Founded in the early 2000s, the company has established itself as a leader in the development of innovative medical technologies and solutions, primarily focusing on diagnostics and therapeutic devices. With a strong operational presence across Europe and North America, BIOMEDICAL is renowned for its cutting-edge products, which include advanced diagnostic kits and state-of-the-art therapeutic equipment. These offerings are distinguished by their precision and reliability, catering to the evolving needs of healthcare professionals. Over the years, BIOMEDICAL has achieved significant milestones, solidifying its market position through strategic partnerships and a commitment to research and development. The company continues to drive advancements in the biomedical field, contributing to improved patient outcomes globally.
DitchCarbon Score
How does BIOMEDICAL's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
BIOMEDICAL's score of 15 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
BIOMEDICAL's reported carbon emissions
BIOMEDICAL, headquartered in "CL", currently does not have available carbon emissions data for recent years. As such, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. However, the company has not outlined any formal reduction targets or commitments to climate initiatives, which may indicate a need for further development in their sustainability strategy. In the context of the industry, it is essential for companies to establish clear climate commitments and reduction goals to align with global efforts to mitigate climate change. As BIOMEDICAL moves forward, it may benefit from setting measurable targets and engaging in initiatives that contribute to reducing their carbon footprint, thereby enhancing their environmental responsibility and sustainability profile.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
BIOMEDICAL is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
